Renal organic anion transporter 1 is maldistributed and diminishes in proximal tubule cells but increases in vasculature after ischemia and reperfusion

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 6, 2008, Pages

  Kwon, Osun ^a   Wang, Wei Wei ^a   Miller, Shane ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Confocal microscopy; Ischemic acute renal failure; Renal tubular function

Indexed keywords

ORGANIC ANION TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; THREE DIMENSIONAL IMAGING; VASCULARIZATION; WESTERN BLOTTING;

EID: 57349102370     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90409.2008     Document Type: Article

References (50)

1. Ali T, Khan I, Simpson W, Prescott G, Townend J, Smith W, MacLeod A. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18: 1292-1298, 2007.
2. Cha SH, Sekine T, Fukushima J, Kanai Y, Kobayashi Y, Goya T, Endou H. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59: 1277-1286, 2001.
3. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus M. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 155: 1505-1511, 1995.
4. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 62: 986-996, 2002.
5. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD. PAH extraction and estimation of plasma flow in human postischemic acute renal failure: a study of the renal allograft. Am J Physiol Renal Physiol 277: F312-F318, 1999.
6. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, Berland Y, Brunet P. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and would repair. Kidney Int 65: 442-451, 2004.
7. Dzurik R, Spustova V, Krivosikova Z, Gazdikova K. Hippurate participates in the correction of metabolic acidosis. Kidney Int 78: S278-S281, 2001.
8. Gulyassy PF, Jarrard E, Stanfel LA. Contribution of hipppurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humans. Biochem Pharm 36: 4215-4220, 1987.
9. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther 305: 1087-1097, 2003.
10. Hicke L. Protein regulation by monoubiquitin. Nat Rev Molecular Cell Biology 2: 195-201, 2001.
11. Hosoyamada M, Sekine T, Kanai Y, Endou H. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol Renal Physiol 276: F122-F128, 1999.
12. Kawashima Y, Sanaka T, Sugino N, Takahashi M, Mizoguchi H. Suppressive effect of quinolinic acid and hippuric acid on bone marrow erythroid growth and lymphocyte blast formation in uremia. Adv Exp Med Biol 223: 69-72, 1987.
13. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 20: 4-19, 2000.
14. Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H. Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 13: 848-857, 2002.
15. +-ATPase during postischemic injury to the renal allograft. Kidney Int 55: 963-975, 1999.
16. Kwon O, Hong S, Blouch K. Alteration in renal organic anion transporter 1 after ischemia/reperfusion in cadaveric renal allografts. J Histochem Cytochem 55: 575-584, 2007.
17. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1516-1517, 1996.
18. Liano F, Pascual J. Outcomes in acute renal failure. Semin Nephrol 18: 541 550, 1998.
19. Ljubojevic M, Balen D, Breljak D, Kusan M, Anzai N, Bahn A, Burckhardt G, Saboli I. Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am J Physiol Renal Physiol 292: F361-F372, 2007.
20. Ljubojevic M, Herak-Kramberger CM, Hagos Y, Bahn A, Endou H, Burckhardt G, Sabolic I. Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol 287: F124-F138, 2004.
21. Lu R, Chan BS, Schuster VL. Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am J Physiol Renal Physiol 276: F295-F303, 1999.
22. Matsuzaki T, Watanabe H, Yoshitome K, Morisak T, Hamada A, Nonoguchi H, Kohda Y, Tomita K, Inui K, Saito H. Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure. Kidney Int 71: 539-547, 2007.
23. Moller JV, Sheikh MI. Renal organic anion transport system: pharmacological, physiological, and biochemical aspects. Pharmacol Rev 34: 315-358, 1983.
24. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13: 866-874, 2002.
25. Motojima M, Hosokawa A, Yamato H, Muraki T, Yoshioka T. Uremic toxins induce proximal tubular injury via organic anion transporter-1 mediated uptake. Br J Pharm 135: 555-563, 2002.
26. Nelson WJ, Rodriguez-Boulan E. Unravelling protein sorting. Nat Cell Biol 6: 282-284, 2004.
27. Niwa T. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Seminars Nephrology 16: 167-182, 1996.
28. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, Terasaki T. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83: 57-66, 2002.
29. Ohtsuki S, Takizawa T, Takanaga H, Hori S, Hosoya K, Terasaki T. Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells. J Neurochem 90: 743-749, 2004.
30. Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, Endou H, Johnson RJ. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 17: 1791-1795, 2006.
31. Ringoir S. An update on uremic toxins. Kidney Int Suppl 52: s2-s4, 1997.
32. Russel FG, Masereeuw R, van Aubel RA. Molecular aspects of renal anion drug transport. Annu Rev Physiol 64: 563-594, 2002.
33. Satoh M, Hayashi H, Watanabe M, Ueda K, Yamato H, Yoshioka T, Motojima M. Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure. Nephron Exp Nephrol 95: e111-e118, 2003.
34. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of paraaminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605, 2007.
35. Sekine T, Cha SH, Endou H. The multispecific organic anion transporter (OAT) family. Pflúgers Arch 440: 337-350, 2000.
36. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429: 179-182, 1998.
37. Spustova V, Cernay P, Golier I. Inhibition of glucose utilization in uremia by hippurate: liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification. J Chromatography 490: 186-192, 1989.
38. Sun W, Wu RR, Poelje PD, Erion MD. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 283: 417-422, 2001.
39. Sweet DH, Bush KT, Nigam SK. The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol Renal Physiol 281: F197-F205, 2001.
40. Sweet DH, Wolf N, Pritchard JB. Expression cloning and characterization of ROAT1. J Biol Chem 272: 30088-30095, 1997.
41. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
42. Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, Endou H. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10: 464-471, 1999.
43. Tsutsumi Y, Deguchi T, Takano M, Takadate A, Lindup WE, Otagiri M. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat. J Pharmacol Exp Ther 303: 880-887, 2002.
44. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818, 2005.
45. Van Aubel RA, Masereeuw R, Russel FG. Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279: F216-F232, 2000.
46. Vanholder R, De Smet R. Pathophysiologic effects of uremic retention solutes. J Am Soc Nephrol 10: 1815-1823, 1999.
47. Vanholder R, De Smet R, Lamere N. Protein-bound uremic solutes: the forgotten toxins. Kidney Int Suppl 59: s266 -s270, 2001.
48. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 47: 510-517, 1995.
49. Vanholder R, De Smet R, Glorieux G, Dhondt A. Survival of hemodialysis patients and uremic toxin removal. Artificial Organs 27: 218-223, 2003.
50. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006.